New bone formation in an osteoblastic tumor model is increased by endothelin-1 overexpression and decreased by endothelin A receptor blockade

Urology

Volumn 53, Issue 5, 1999, Pages 1063-1069

  Nelson, Joel B ^a   Nguyen, Son H ^a   Wu Wong, Jinshyun R ^c   Opgenorth, Terry J ^c   Dixon, Douglas B ^c   Chung, Leland W K ^d   Inoue, Nozomu ^b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ABBOTT LABORATORIES   (United States)

^d UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; COMPLEMENTARY DNA; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; MESSENGER RNA; PROTEIN;

ANIMAL MODEL; ARTICLE; BONE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; NORTHERN BLOTTING; OSSIFICATION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION;

ANIMALS; BONE NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; MALE; MICE; MICE, NUDE; OSSIFICATION, HETEROTOPIC; OSTEOBLASTOMA; PROSTATIC NEOPLASMS; RECEPTOR, ENDOTHELIN A; RECEPTORS, ENDOTHELIN;

EID: 0033010543     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(98)00658-X     Document Type: Article

References (31)

1. Nelson J.B., Hedican S.P., George D.J., et al. Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate. Nature Med. 1:1995;944-949.
2. Nelson J.B., Chan-Tack K., Hedican S.P., et al. Endothelin production and decreased endothelin B receptor expression in advanced prostate cancer. Cancer Res. 56:1996;663-668.
3. Walden P.D., Ittmann M., Monaco M.E., et al. Endothelin-1 production and agonist activities in cultured prostate-derived cells implications for regulation of endothelin bioactivity and bioavailability in prostatic hyperplasia . Prostate. 34:1998;241-250.
4. Casey M.L., Byrd W., MacDonald P.C. Massive amounts of immunoreactive endothelin in human seminal fluid. J Clin Endocrinol Metab. 74:1992;223-225.
5. 2+ from extra- and intracellular pools in osteoblastic cells. Am J Physiol. 257:1989;E797-E803.
6. Takuwa Y., Masaki T., Yamashita K. The effects of the endothelin family peptides on cultured osteoblastic cells from rat calvariae. Biochem Biophys Res Commun. 170:1990;998-1005.
7. Shioide M., Noda M. Endothelin modulates osteopontin and osteocalcin messenger ribonucleic acid expression in rat osteoblastic osteosarcoma cells. J Cell Biochem. 53:1993;176-180.
8. Alam A.S.M.T., Gallagher A., Shankar V., et al. Endothelin inhibits osteoclastic bone resorption by a direct effect on cell motility implications for the vascular control of bone resorption . Endocrinology. 130:1992;3617-3624.
9. Kaighn M.E., Narayan K.S., Ohnuki Y., et al. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol. 17:1979;16-23.
10. Perkel V.S., Mohan S., Herring S.J., et al. Human prostatic cancer cells, PC3, elaborate mitogenic activity which selectively stimulates human bone cells. Cancer Res. 50:1990;6902-6907.
11. Shevrin D.H., Kukreja S.C., Ghosh L., et al. Development of skeletal metastasis by human prostatic cancer in athymic nude mice. Clin Exp Metastasis. 6:1988;401-409.
12. Thalmann G.N., Anezinis P.E., Chang S.-M., et al. Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. Cancer Res. 54:1994;2577-2581.
13. Hayflick L. The establishment of a line (WISH) of human amnion cells in continuous cultivation. Exp Cell Res. 23:1961;14-20.
14. Wlodarski K., Hinek A., Ostrowski K. Investigations on cartilage and bone induction in mice grafted with FL and WISH line human amniotic cells. Calc Tissue Res. 5:1970;70-79.
15. Wlodarski K.H. Orthotopic and ectopic chondrogenesis and osteogenesis mediated by neoplastic cells. Clin Orthop. 200:1985;248-265.
16. Izbicka E., Dunstan C., Esparza J., et al. Human amniotic tumor that induces new bone formation in vivo produces a growth-regulatory activity in vitro for osteoblasts identified as an extended form of basic fibroblast growth factor. Cancer Res. 56:1996;633-636.
17. Alberts G.F., Peifley K.A., Johns A., et al. Constitutive endothelin-1 overexpression promotes smooth muscle cell proliferation via an external autocrine loop. J Biol Chem. 269:1994;10112-10118.
18. Judd A.M., Login I.S., Kovacs K., et al. Characterization of the MMQ cell, a prolactin-secreting clonal cell line that is responsive to dopamine. Endocrinology. 123:1988;2341-2350.
19. Wu-Wong J.R., Chiou W., Magnuson S.R., et al. Identification and characterization of type A endothelin receptors in MMQ cells. Mol Pharmacol. 44:1993;285-291.
20. A-selective receptor antagonist . J Pharmacol Exp Ther. 276:1996;473-481.
21. Opgenorth TJ, Adler AL, Wu-Wong JR, et al: Pharmacology of A-192621, a nonpeptide, orally active, ETB receptor antagonist (abstract). Proceedings of the Fifth International Conference on Endothelin, September 12-15, 1997, Kyoto, Japan.
22. Sunnergren K.P., Word R.A., Sambrook J.F., et al. Expression and regulation of endothelin precursor mRNA in a vascular human amnion. Mol Cell Endocrinol. 68:1990;R7-R14.
23. Battistini B., D'Orleans-Juste P., Sirois P. Endothelins circulating plasma levels and presence in other biological fluids . Lab Invest. 68:1993;600-628.
24. Yamashita J., Ogawa M., Nomura K., et al. Interleukin 6 stimulates the production of immunoreactive endothelin 1 in human breast cancer cells. Cancer Res. 53:1993;464-467.
25. Semler D.E., Ohlstein E.H., Nambi P., et al. Endothelin-1-evoked calcium transients in UMR-106 osteoblastic osteosarcoma cells are mediated through endothelin-A and endothelin-B receptors. J Pharm Exp Ther. 272:1995;1052-1058.
26. Battistini B., Chailler P., D'Orleans-Juste P., et al. Growth regulatory properties of endothelins. Peptides. 14:1993;385-399.
27. Schvartz I., Ittoop O., Davidai G., et al. Endothelin rapidly stimulates tyrosine phosphorylation in osteoblast-like cells. Peptides. 13:1992;159-163.
28. Daub H., Weiss F.U., Wallasch C., et al. Role of transactivation of the EGF receptor in signaling by G-protein-coupled receptors. Nature. 379:1996;557-560.
29. Cronauer M.V., Hittmair A., Eder I.E., et al. Basic fibroblast growth factor levels in cancer cells and in sera of patients suffering from proliferative disorders of the prostate. Prostate. 31:1997;223-233.
30. Gabbianelli M., Sargiacomo M., Pelosi E., et al. "Pure" human hematopoietic progenitors permissive action of basic fibroblast growth factor . Science. 249:1990;1561-1564.
31. Nelson J.B., Sutkowski D.M., Kozlowski J.M. Association of interleukin 6 (IL-6) and granulocyte colony stimulating factor (G-CSF) to nephrogenic hepatic dysfunction (Stauffer's) syndrome. J Urol. 151:1994;484a.